Tuna Based Nuggets and Ischemic Cardiomyopathy (ICMP)

March 5, 2026 updated by: Wajeeha Bashir Baig, University of Lahore Hospital (ULH)

Development and Efficacy Assessment of Tuna-based (Thunnus Albacares) Nuggets on Cardio-metabolic Risk Factors in Ischemic Cardiomyopathy Patients

the study is to evaluate the effect of tuna-based nuggets on cardiomyopathy patients. participants were recruited from cardiology hospital and selenium dose in form of nuggets were given to patients that were enrolled in treatment group for three months. the finding were improved biomarker level(IL-6) and lab investigations.

Study Overview

Status

Completed

Conditions

Intervention / Treatment

Detailed Description

this study aims to assess the effect of a nutritional interventional with tuna based nugget with diet plan on BMI, dietary habits and anti-inflammatory level in blood. as tuna is taken as best source of selenium that is effective for cardiomyopathy patients. Eligible participants received dietary counselling with one slice of fish nugget daily foe 12 weeks. anthropometric measurements, biochemical and anti-inflammatory test was done before and after completion of study. Out of 120 participants, 60 were enrolled as treatment and other 60 as control group with no intervention.

Study Type

Interventional

Enrollment (Actual)

120

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

  • Pakistan
      • Lahore, Pakistan
        • punjab institute of cardiology, Lahore

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

  • Adult
  • Older Adult

Accepts Healthy Volunteers

Yes

Description

Inclusion Criteria

  • Diagnosed ICMP patients post-myocardial infarction
  • Type 2 diabetic patients
  • Age range between 35 to 70 years
  • Overweight individuals (BMI > 25 kg/m²)
  • Presence of dyslipidemia Exclusion Criteria
  • Chronic renal failure
  • Hepatic failure
  • Connective tissue disorders
  • Respiratory failure
  • Hypertrophic cardiomyopathy
  • Heart failure with preserved ejection fraction (EF > 40%)

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Treatment
  • Allocation: N/A
  • Interventional Model: Single Group Assignment
  • Masking: None (Open Label)

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Experimental: tuna fish nuggets
tuna fish nugget having 5g weight each for 12 weeks on daily basis. one nugget per day constitute 55micro gram selenium
Dietary supplement: tuna based nuggets
tuna based nugget(5g) having recommended selenium amount and herbs without frying process.
Other Names:
  • non

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Interleukin (IL-6)
Time Frame: 3months
anti inflammatory marker
3months
C- Reactive Protein(CRP)
Time Frame: 3months
anti-inflammatory marker
3months
Cardiac Kinase(CK)
Time Frame: 3months
Cardiac enzymes
3months

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
BMI(Body Mass Index)
Time Frame: 3 months
Anthropometric measurements
3 months
Fasting Basal Sugar
Time Frame: 3-months
levels below 100mg/dL in samples are considered normal
3-months
Total Cholesterol
Time Frame: 3-months
In blood sample normal value should be less than 200mg/dL. Total cholesterol: <200mg/dL
3-months
Triglycerides
Time Frame: 3-months
In triglycerides, blood test should be between 10-150mg/dL
3-months

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Sponsor

University of Lahore Hospital (ULH)

Publications and helpful links

The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.

General Publications

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

September 15, 2025

Primary Completion (Actual)

January 15, 2026

Study Completion (Actual)

January 25, 2026

Study Registration Dates

First Submitted

February 25, 2026

First Submitted That Met QC Criteria

March 5, 2026

First Posted (Actual)

March 10, 2026

Study Record Updates

Last Update Posted (Actual)

March 10, 2026

Last Update Submitted That Met QC Criteria

March 5, 2026

Last Verified

March 1, 2026

More Information

Terms related to this study

Additional Relevant MeSH Terms

Other Study ID Numbers

  • 123456 (Innovate UK)

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

NO

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Obesity, Metabolically Benign

Clinical Trials on tuna based nuggets

Search Similar Trials

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Serbia

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations

Subscribe